Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions

Addiction. 2011 Dec;106(12):2146-55. doi: 10.1111/j.1360-0443.2011.03520.x. Epub 2011 Aug 18.

Abstract

Aims: Given the rising rates of the non-medical use of prescription medications (NUPM) and strong cross-sectional associations between psychopathology and NUPM, we examined whether a history of NUPM increased the risk for onset and recurrence of psychopathology.

Design: Longitudinal data are from waves 1 and 2 of the National Epidemiological Survey on Alcoholism and Related Conditions (NESARC).

Setting: The NESARC is a nation-wide, household-based survey.

Participants: A total of 34,653 US resident participants who completed both NESARC waves were included in analyses.

Measurements: Primary measures were history of NUPM and Axis I psychopathology at wave 1. Wave 1 personality disorder diagnosis and sociodemographic characteristics were used as control variables.

Findings: Design-based logistic regression analyses indicated that life-time and past year NUPM at wave 1 increased risk for onset of psychopathology among those with no history of psychopathology at baseline, with particular risk for non-NUPM substance use and bipolar disorders. Life-time and past year NUPM were associated with recurrence of alcohol and non-NUPM substance use disorders among those with these diagnoses at baseline. In contrast, life-time and past year NUPM was associated with the onset of all examined disorders among those with a different diagnosis at baseline.

Conclusions: Non-medical use of prescription medications is a consistent risk factor for the onset and recurrence of psychopathology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Causality
  • Central Nervous System Depressants / administration & dosage*
  • Central Nervous System Depressants / adverse effects
  • Central Nervous System Depressants / therapeutic use
  • Central Nervous System Stimulants / administration & dosage*
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / therapeutic use
  • Epidemiologic Methods
  • Female
  • Humans
  • Male
  • Mental Disorders / epidemiology*
  • Middle Aged
  • Prescription Drugs / therapeutic use*
  • Psychopathology
  • Recurrence
  • Self Medication / adverse effects*
  • Self Medication / statistics & numerical data
  • Substance-Related Disorders / epidemiology

Substances

  • Central Nervous System Depressants
  • Central Nervous System Stimulants
  • Prescription Drugs